37
Registered trials
15
Recruiting
21
Completed trials
22
Sponsors
21
Countries
Phase III:
8
Phase II/III:
1
Phase II:
19
Phase I/II:
6
Phase IV:
1
Phase I (Other):
1
Phase I (FiH):
1
Oversight events:
2 serious breaches
5 temporary halts
3 urgent safety measures
across 5 trials
View oversight register →
Indications tested
Squamous cell carcinoma of head and neck
3
Non-small cell lung cancer
3
Endometrial cancer stage III
2
Endometrial cancer
2
Hepatic cancer
1
Metastatic gastric cancer
1
Oropharyngeal squamous cell carcinoma
1
Rectal cancer
1
Adenocarcinoma of colon
1
DNA mismatch repair deficiency test
1
Endometrial cancer stage II
1
Head and neck cancer
1
Sponsors using this IMP
Glaxosmithkline Research & Development Limited
13
Grupo Espanol De Investigacion En Cancer De Ovario
2
Tesaro Inc.
2
Unicancer
2
Arcagy Gineco
1
Asso De Recherche Cancers Gynecologiques
1
Centre Hospitalier Universitaire De Dijon
1
Centre Leon Berard
1
Fondazione GONO Plus
1
Fondazione IRCCS Istituto Nazionale Dei Tumori
1
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
1
G.O.I.R.C. Gruppo Oncologico Italiano Di Ricerca Clinica
1
All trials — page 2
37 totalShowing 25–37 of 37 trials